Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date
Katja Weisel Department of Hematology/Oncology, University Hospital Tuebingen, Tuebingen, Germany Abstract: Despite advances in the treatment of multiple myeloma, it remains an incurable disease, with relapses and resistances frequently observed. Recently, immunotherapies, in particular, monoclona...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-10-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/spotlight-on-elotuzumab-in-the-treatment-of-multiple-myeloma-the-evide-peer-reviewed-article-OTT |